Endothelial dysfunction and inflammation in patients with non-obstructive coronary arteries

N N Pakhtusov1, A O Iusupova1, E V Privalova1

  • 1I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.

Kardiologiia
|March 18, 2021
PubMed

Insights

Patients with non-obstructive coronary artery disease show higher endothelin-1 levels and endothelial dysfunction, suggesting a role in ischemic heart disease (IHD) pathogenesis. Tumor necrosis factor-alpha was not a useful marker in this study.

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Endothelial Function

Background:

  • Ischemic heart disease (IHD) pathogenesis is complex and may involve factors beyond obstructive coronary artery disease (CAD).
  • Endothelial dysfunction and inflammation are implicated in cardiovascular disease progression.
  • Specific biomarkers like endothelin-1, E-selectin, and TNF-α are associated with endothelial dysfunction and inflammation.

Purpose of the Study:

  • To investigate levels of endothelin-1, E-selectin, and TNF-α in patients with IHD.
  • To compare these markers between patients with non-obstructive and obstructive coronary artery (CA) disease.
  • To assess the association between endothelial dysfunction markers and IHD in the absence of significant CA stenosis.

Main Methods:

  • Study included 32 patients with verified IHD, divided into non-obstructive (n=19) and obstructive (n=13) CA disease groups.
  • Endothelial dysfunction assessed using photoplethysmography and videocapillaroscopy.
  • Serum concentrations of endothelin-1, E-selectin, and TNF-α were measured.

Main Results:

  • Patients with non-obstructive CA disease exhibited a trend towards more pronounced endothelial dysfunction compared to the obstructive group, though not statistically significant.
  • Significantly higher concentrations of endothelin-1 were observed in the IHD group with non-obstructive CA disease (0.45 ng/ml) versus those with atherosclerotic stenosis (0.35 ng/ml, p=0.035).
  • E-selectin concentrations did not differ significantly between groups. TNF-α levels were below the detection threshold in both groups.

Conclusions:

  • Endothelial dysfunction and elevated endothelin-1 in non-obstructive CA disease may contribute to IHD pathogenesis.
  • These findings suggest potential mechanisms for IHD development independent of hemodynamically significant CA stenoses.
  • Low TNF-α levels precluded its use as a diagnostic marker; further research with larger cohorts and alternative markers is warranted.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
165
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
633
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
140
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
138
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
143
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
2.3K